UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

All‐in‐One Nanomedicine: Multifunctional Single‐Component Nanoparticles for Cancer Theranostics

Small (Weinheim an der Bergstrasse, Germany), 2021-12, Vol.17 (52), p.e2103072-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma

Journal of cancer research and clinical oncology, 2021-05, Vol.147 (5), p.1275-1286

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release

Journal of controlled release, 2020-07, Vol.323, p.565-577

2020

Link zum Volltext

Verfügbarkeit prüfen

Jellyfish-Shaped Amphiphilic Dendrimers: Synthesis and Formation of Extremely Uniform Aggregates

Macromolecules, 2014-02, Vol.47 (3), p.916-921

2014

Link zum Volltext

Verfügbarkeit prüfen

Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy

Small (Weinheim an der Bergstrasse, Germany), 2016-10, Vol.12 (37), p.5108-5119

2016

Link zum Volltext

Verfügbarkeit prüfen

Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin

International journal of pharmaceutics, 2019-09, Vol.568, p.118499-118499, Article 118499

2019

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation

Theranostics, 2021-01, Vol.11 (17), p.8587-8604

2021

Link zum Volltext

Verfügbarkeit prüfen

A versatile chitosan nanogel capable of generating AgNPs in-situ and long-acting slow-release of Ag+ for highly efficient antibacterial

Carbohydrate polymers, 2021-04, Vol.257, p.117636-117636, Article 117636

2021

Link zum Volltext

Verfügbarkeit prüfen

Copper as the Target for Anticancer Nanomedicine

Advanced therapeutics, 2019-05, Vol.2 (5), p.n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer

Journal of colloid and interface science, 2024-10, Vol.671, p.216-231

2024

Link zum Volltext

Verfügbarkeit prüfen

Interface cisplatin-crosslinked doxorubicin-loaded triblock copolymer micelles for synergistic cancer therapy

Colloids and surfaces, B, Biointerfaces, 2020-12, Vol.196, p.111334, Article 111334

2020

Link zum Volltext

Verfügbarkeit prüfen

Retraction notice to “Ca2+/Calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer” [Cancer Lett. 344(1) (2014) 119–128]

Cancer letters, 2018-02, Vol.414, p.312-312

2018

Link zum Volltext

Verfügbarkeit prüfen

Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo

Advanced healthcare materials, 2016-10, Vol.5 (19), p.2517-2527

2016

Link zum Volltext

Verfügbarkeit prüfen

Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7‐Ethyl‐10‐Hydroxycamptothecin

Advanced healthcare materials, 2018-04, Vol.7 (7), p.e1701140-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Ca2+/calmodulin-dependent protein kinase II gamma , a critical mediator of the NF- Kappa B network, is a novel therapeutic target in non-small cell lung cancer

Cancer letters, 2014-03, Vol.344 (1), p.119-128

2014

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to 'Ca 2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer' [Cancer Lett. 344 (1), 119-128; March 1, 2014]

Cancer letters, 2016-10, Vol.380 (2), p.609

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Ca2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer’ [Cancer Lett. 344 (1), 119–128; March 1, 2014]

Cancer letters, 2016-10, Vol.380 (2), p.609-610

2016

Link zum Volltext

Verfügbarkeit prüfen

Ca2+/calmodulin-dependent protein kinase II[gamma], a critical mediator of the NF-[kappa]B network, is a novel therapeutic target in non-small cell lung cancer

Cancer letters, 2014-03, Vol.344 (1), p.119

2014

Link zum Volltext

Verfügbarkeit prüfen

RETRACTED: Ca2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer

Cancer letters, 2014-03, Vol.344 (1), p.119-128

2014

Link zum Volltext

Verfügbarkeit prüfen

RETRACTED: Ca(2+)/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer

Cancer letters, 2014-03, Vol.344 (1), p.119-128

2014

Link zum Volltext

Verfügbarkeit prüfen

Synergy of 5-aminolevulinate supplement and CX3CR1 suppression promotes liver regeneration via elevated IGF-1 signaling

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112984-112984, Article 112984

2023

Link zum Volltext

Verfügbarkeit prüfen

The 2023 Mw7.7 Pazarcik earthquake caused a reversal in vertical motion along the SW branch of the East Anatolian fault

Journal of structural geology, 2024-07, Vol.184, p.105172, Article 105172

2024

Link zum Volltext

Verfügbarkeit prüfen

Mesoporous Carbon Spheres: Synthesis, Characterization and Supercapacitance

International journal of electrochemical science, 2009-08, Vol.4 (8), p.1063-1073

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

All‐in‐One Nanomedicine: Multifunctional Single‐Component Nanoparticles for Cancer Theranostics

The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma

Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release

Jellyfish-Shaped Amphiphilic Dendrimers: Synthesis and Formation of Extremely Uniform Aggregates

Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy

Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin

Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation

A versatile chitosan nanogel capable of generating AgNPs in-situ and long-acting slow-release of Ag+ for highly efficient antibacterial

Copper as the Target for Anticancer Nanomedicine

Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer

Interface cisplatin-crosslinked doxorubicin-loaded triblock copolymer micelles for synergistic cancer therapy

Retraction notice to “Ca2+/Calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer” [Cancer Lett. 344(1) (2014) 119–128]

Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo

Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7‐Ethyl‐10‐Hydroxycamptothecin

Ca2+/calmodulin-dependent protein kinase II gamma , a critical mediator of the NF- Kappa B network, is a novel therapeutic target in non-small cell lung cancer

Corrigendum to 'Ca 2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer' [Cancer Lett. 344 (1), 119-128; March 1, 2014]

Corrigendum to ‘Ca2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer’ [Cancer Lett. 344 (1), 119–128; March 1, 2014]

Ca2+/calmodulin-dependent protein kinase II[gamma], a critical mediator of the NF-[kappa]B network, is a novel therapeutic target in non-small cell lung cancer

RETRACTED: Ca2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer

RETRACTED: Ca(2+)/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer

Cold protection allows local cryotherapy in a clinical-relevant model of traumatic optic neuropathy

Synergy of 5-aminolevulinate supplement and CX3CR1 suppression promotes liver regeneration via elevated IGF-1 signaling

The 2023 Mw7.7 Pazarcik earthquake caused a reversal in vertical motion along the SW branch of the East Anatolian fault

Mesoporous Carbon Spheres: Synthesis, Characterization and Supercapacitance

Aktive Filter

Suchergebnisse filtern